.png)
.png)
Head of Clinical Development
Rebiotix, a Ferring Company
Disclosure(s): Rebiotix, a Ferring Company: Employee
Dr. Lindy Bancke joined Rebiotix, a Ferring Company, in 2018 with a strong background in clinical development and strategic leadership at biotech and mid-size pharmaceutical companies. Dr. Bancke's clinical and program leadership experience spans the spectrum of drug development, from first-in-human studies to global Phase 3 trials, as well as products with orphan designation, fast track status, and unique regulatory pathways. In her current position as Head of Clinical Development at Rebiotix, she leads a team of professionals in Clinical Research, Clinical Operations, and Clinical Recruitment, focused on harnessing the power of the human microbiome to revolutionize the treatment of challenging diseases.